MicroRNAs as anti-cancer therapy
- PMID: 24479801
- DOI: 10.2174/1381612820666140128211346
MicroRNAs as anti-cancer therapy
Abstract
MicroRNAs (miRNAs) are endogenously expressed and evolutionarily conserved small non-coding RNAs, which regulate gene expression. Several studies have shown that they are involved in fundamental biological processes, such as proliferation and apoptosis. MicroRNA dysregulation plays an important role in cancer onset and progression where miRs can function as both tumor promoters (oncomiRs) or tumor suppressors by targeting numerous biomolecules that are important in carcinogenesis. MicroRNA molecules are already entering the clinic as diagnostic and prognostic biomarkers for patient stratification and also as therapeutic targets and agents. Their role as biomarkers and therapeutic targets is appealing but several obstacles have as yet limited our ability to translate this potential into a clinical reality. This review provides a comprehensive overview of miRNAs with established functional relevance in cancer. Furthermore, approaches towards therapeutic miRNA-based intervention are discussed. Those include viral or non-viral approaches of miRNA replacement therapy in the case of tumor-suppressing miRNAs and strategies for the inhibition of oncogenic miRNAs.
Similar articles
-
Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.Microrna. 2020;9(3):198-215. doi: 10.2174/2211536608666191104103834. Microrna. 2020. PMID: 31686643
-
MicroRNA in cancer: new hopes for antineoplastic chemotherapy.Ups J Med Sci. 2012 May;117(2):202-16. doi: 10.3109/03009734.2012.660551. Epub 2012 Feb 21. Ups J Med Sci. 2012. PMID: 22348396 Free PMC article. Review.
-
The P53/microRNA network: A potential tumor suppressor with a role in anticancer therapy.Pharmacol Res. 2020 Oct;160:105179. doi: 10.1016/j.phrs.2020.105179. Epub 2020 Sep 3. Pharmacol Res. 2020. PMID: 32890739 Review.
-
MicroRNAs and cancer; an overview.Curr Pharm Biotechnol. 2014;15(5):430-7. doi: 10.2174/1389201015666140519095304. Curr Pharm Biotechnol. 2014. PMID: 24846068 Review.
-
MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy.Curr Pharm Des. 2013;19(7):1242-52. doi: 10.2174/138161213804805739. Curr Pharm Des. 2013. PMID: 23570052 Review.
Cited by
-
Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies.Naunyn Schmiedebergs Arch Pharmacol. 2024 May 18. doi: 10.1007/s00210-024-03153-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38761210 Review.
-
Sodium hyaluronate promotes proliferation, autophagy, and migration of corneal epithelial cells by downregulating miR-18a in the course of corneal epithelial injury.Eur J Histochem. 2023 Jun 15;67(2):3663. doi: 10.4081/ejh.2023.3663. Eur J Histochem. 2023. PMID: 37322995 Free PMC article.
-
MiRNAs as Potential Regulators of Enthesis Healing: Findings in a Rodent Injury Model.Int J Mol Sci. 2023 May 10;24(10):8556. doi: 10.3390/ijms24108556. Int J Mol Sci. 2023. PMID: 37239902 Free PMC article.
-
lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1.J Oncol. 2022 Oct 11;2022:1366511. doi: 10.1155/2022/1366511. eCollection 2022. J Oncol. 2022. PMID: 36268275 Free PMC article.
-
FBP1 /miR-24-1/enhancer axis activation blocks renal cell carcinoma progression via Warburg effect.Front Oncol. 2022 Aug 1;12:928373. doi: 10.3389/fonc.2022.928373. eCollection 2022. Front Oncol. 2022. PMID: 35978816 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources